Why and how would we implement a lung cancer screening program?

Public Health Reviews

Volumn 36, Issue 1, 2015, Pages

  Guessous, Idris ^a,b,c   Cornuz, Jacques ^d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Evidence; Implementation; Low dose computed tomography; Lung cancer; Overdiagnosis; Screening; Smoking

Indexed keywords

CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CAUSE OF DEATH; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FALSE POSITIVE RESULT; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH PROGRAM; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG CANCER; POPULATION RESEARCH; RADIATION EXPOSURE; REVIEW; SMOKING CESSATION PROGRAM; THORAX RADIOGRAPHY; TREND STUDY;

EID: 84981489365     PISSN: 03010422     EISSN: 21076952     Source Type: Journal    
DOI: 10.1186/s40985-015-0010-3     Document Type: Review

References (58)

1. Guessous I, Cornuz J, Paccaud F. Lung cancer screening: current situation and perspective. Swiss Med Wkly. 2007;137(21-22):304-11.
2. Tammemagi MC, Lam S. Screening for lung cancer using low dose computed tomography. BMJ. 2014;348:g2253.
3. Jett JR. Screening for lung cancer with low-dose CT scans. Respir Investig. 2013;51(4):205-6.
4. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377(9760):127-38.
5. Jett JR, Midthun DE. Screening for lung cancer: for patients at increased risk for lung cancer, it works. Ann Intern Med. 2011;155(8):540-2.
6. Spiro SG, Navani N. Screening for lung cancer: is this the way forward? Respirology. 2012;17(2):237-46.
7. Guessous I, Cornuz J, Gaspoz JM, Paccaud F. Screening: principles and methods. Rev Med Suisse. 2010;6(256):1390-4.
8. Cornuz J, Junod N, Pasche O, Guessous I. Cancer screening in clinical practice: the value of shared decisionmaking. Rev Med Suisse. 2010;6(256):1410-4.
9. Youlden DR, Cramb SM, Baade PD. The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J Thorac Oncol. 2008;3(8):819-31.
10. Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368(4):351-64.
11. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321(7257):323-9.
12. Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011;306(17):1865-73.
13. Mulshine JL, Smith RA. Lung cancer. 2: screening and early diagnosis of lung cancer. Thorax. 2002;57(12):1071-8.
14. Miettinen OS. The clinical trial as a paradigm for epidemiologic research. J Clin Epidemiol. 1989;42(6):491-6. discussion 497-8.
15. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
16. Miller AB. Screening for lung cancer with low-dose computed tomography. Oncologist. 2013;18(8):897-9.
17. Silvestri GA. Screening for lung cancer: it works, but does it really work? Ann Intern Med. 2011;155(8):537-9.
18. Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst. 2010;102(23):1771-9.
19. Aberle DR, Abtin F, Brown K. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol. 2013;31(8):1002-8.
20. Kanne JP. Screening for lung cancer: what have we learned? AJR Am J Roentgenol. 2014;202(3):530-5.
21. Gould MK. Lung cancer screening and elderly adults: do we have sufficient evidence? Ann Intern Med. 2014;161(9):672-3.
22. Park YS. Lung cancer screening: subsequent evidences of national lung screening trial. Tuberc Respir Dis (Seoul). 2014;77(2):55-9.
23. Arenberg D. Lung cancer screening. Semin Respir Crit Care Med. 2013;34(6):727-37.
24. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307(22):2418-29.
25. Heuvers ME, Wisnivesky J, Stricker BH, Aerts JG. Generalizability of results from the National Lung Screening Trial. Eur J Epidemiol. 2012;27(9):669-72.
26. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e78S-92.
27. van den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, van Klaveren RJ, de Koning HJ. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J. 2011;38(1):154-61.
28. O'Connor GT, Hatabu H. Lung cancer screening, radiation, risks, benefits, and uncertainty. JAMA. 2012;307(22):2434-5.
29. Ruano-Ravina A, Perez Rios M, Fernandez-Villar A. Lung cancer screening with low-dose computed tomography after the National Lung Screening Trial. The debate is still open. Arch Bronconeumol. 2013;49(4):158-65.
30. Grannis Jr FW. Minimizing over-diagnosis in lung cancer screening. J Surg Oncol. 2013;108(5):289-93.
31. Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330-8.
32. Patz Jr EF, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemagi MC, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014;174(2):269-74.
33. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-13.
34. Pyenson BS, Sander MS, Jiang Y, Kahn H, Mulshine JL. An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood). 2012;31(4):770-9.
35. McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011;6(11):1841-8.
36. Shmueli A, Fraifeld S, Peretz T, Gutfeld O, Gips M, Sosna J, et al. Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience. Value Health. 2013;16(6):922-31.
37. Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med. 2014;371(19):1793-802.
38. Greif JM. Mammographic screening for breast cancer: An invited review of the benefits and costs. Breast. 2010;19(4):268-72.
39. Sharaf RN, Ladabaum U. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Am J Gastroenterol. 2013;108(1):120-32.
40. Goulart BH, Ramsey SD. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs. Oncologist. 2013;18(8):941-6.
41. McKee BJ, McKee AB, Flacke S, Lamb CR, Hesketh PJ, Wald C. Initial experience with a free, high-volume, low-dose CT lung cancer screening program. J Am Coll Radiol. 2013;10(8):586-92.
42. Boiselle PM, White CS, Ravenel JG. Computed tomographic screening for lung cancer: current practice patterns at leading academic medical centers. JAMA Intern Med. 2014;174(2):286-7.
43. Pinsky PF, Berg CD. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen. 2012;19(3):154-6.
44. Chiles C. Lung cancer screening with low-dose computed tomography. Radiol Clin North Am. 2014;52(1):27-46.
45. Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst. 2011;103(13):1058-68.
46. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013;369(3):245-54.
47. Pinsky PF, Gierada DS, Hocking W, Patz Jr EF, Kramer BS. National lung screening trial findings by age: medicareeligible versus under-65 population. Ann Intern Med. 2014;161(9):627-33.
48. Wiener RS. Balancing the benefits and harms of low-dose computed tomography screening for lung cancer: Medicare's options for coverage. Ann Intern Med. 2014;161(6):445-6.
49. Clark MA, Gorelick JJ, Sicks JD, Park ER, Graham AL, Abrams DB, et al. The Relations between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Cancer Screening Trial: Implications for Public Health. Nicotine Tob Res. 2015.
50. Kahende JW, Loomis BR, Adhikari B, Marshall L. A review of economic evaluations of tobacco control programs. Int J Environ Res Public Health. 2009;6(1):51-68.
51. Cornuz J, Pinget C, Gilbert A, Paccaud F. Cost-effectiveness analysis of the first-line therapies for nicotine dependence. Eur J Clin Pharmacol. 2003;59(3):201-6.
52. Arenberg D, Kazerooni EA. Setting up a lung cancer screening program. J Natl Compr Canc Netw. 2012;10(2):277-85.
53. Rosen MP, Corey J, Siewert B. Establishing a computed tomography screening clinic. J Thorac Imaging. 2012;27(4):220-3.
54. Aboyans V, Guessous I, Leclerc A, Lacroix P. From guidelines for screening to their (poor) implementation: the case of the abdominal aortic aneurysm. Rev Med Suisse. 2010;6(256):1405-9.
55. Miller Jr DP, Reuland DS. Controversies in cancer screening. N C Med J. 2014;75(4):253-6.
56. Wender R, Fontham ET, Barrera Jr E, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):107-17.
57. Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60(2):70-98.
58. Stefanek ME. Uninformed compliance or informed choice? A needed shift in our approach to cancer screening. J Natl Cancer Inst. 2011;103(24):1821-6.